Market Cap 125.60B
Revenue (ttm) 11.02B
Net Income (ttm) -535.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 31.12
Profit Margin -4.86%
Debt to Equity Ratio 0.00
Volume 491,634
Avg Vol 1,503,022
Day's Range N/A - N/A
Shares Out 256.79M
Stochastic %K 51%
Beta 0.50
Analysts Strong Sell
Price Target $506.85

Latest News on VRTX

GreensKeeper Q1 2025 Portfolio Update

Apr 10, 2025, 8:55 AM EDT - 12 days ago

GreensKeeper Q1 2025 Portfolio Update

AXP CHKP ELV GOOG GOOGL ICE ICLR


Vertex Announces Program Updates for Type 1 Diabetes Portfolio

Mar 28, 2025, 4:05 PM EDT - 24 days ago

Vertex Announces Program Updates for Type 1 Diabetes Portfolio


Final Trades: Vertex Pharma, Netflix and the IYF

Mar 27, 2025, 5:14 PM EDT - 25 days ago

Final Trades: Vertex Pharma, Netflix and the IYF

NFLX IYF


Trade Tracker: Steve Weiss buys Vertex Pharmaceuticals

Mar 24, 2025, 1:19 PM EDT - 4 weeks ago

Trade Tracker: Steve Weiss buys Vertex Pharmaceuticals


Vertex to Participate in Upcoming March Investor Conferences

Feb 18, 2025, 4:05 PM EST - 2 months ago

Vertex to Participate in Upcoming March Investor Conferences


Vertex Pharmaceuticals' Revenue Forecast Tops Expectations

Feb 10, 2025, 4:40 PM EST - 2 months ago

Vertex Pharmaceuticals' Revenue Forecast Tops Expectations


FDA approves a new painkiller for the first time in decades

Jan 31, 2025, 11:39 AM EST - 2 months ago

FDA approves a new painkiller for the first time in decades


What's Happening With VRTX Stock?

Jan 31, 2025, 9:32 AM EST - 2 months ago

What's Happening With VRTX Stock?